Clinical trials
Phase 2 Agnosia trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
71 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 3 |
| 2005 | 1 |
| 2007 | 7 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 4 |
| 2014 | 5 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 2 |
| 2018 | 4 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 1 |
| 2024 | 5 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 48 |
| Terminated | 11 |
| Recruiting | 7 |
| Unknown status | 2 |
| Not yet recruiting | 1 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Baudax Bio | 4 |
| Pacira Pharmaceuticals, Inc | 4 |
| Heron Therapeutics | 3 |
| Johns Hopkins University | 3 |
| University of Chicago | 3 |
| Antonios Likourezos | 2 |
| AstraZeneca | 2 |
| Brigham and Women's Hospital | 2 |
| Icahn School of Medicine at Mount Sinai | 2 |
| Pfizer | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Agnosia | 71 |
| Pain | 22 |
| Postoperative Pain | 15 |
| Neuralgia | 8 |
| Chronic Pain | 5 |
| Opioid-Related Disorders | 5 |
| Bunion | 4 |
| Spinal Cord Injuries | 4 |
| Anemia, Sickle Cell | 3 |
| Diabetic Neuropathies | 3 |
Trials
Showing 1 to 25 of 71. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.